Synthesis and antibacterial activity of lipophilic carbapenems with anti-MRSA activity

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 20, 1996, Pages 2449-2454

  Arnould, Jean Claude ^a   Illingworth, Ruth N ^b   Nichols, Wright W ^b   Wilson, R Geoffrey ^b  

^a Zeneca Pharma   (France)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; IMIPENEM; L 695256; PENICILLIN BINDING PROTEIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG PROTEIN BINDING; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STRUCTURE ACTIVITY RELATION;

ENTEROCOCCUS FAECALIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0030598172     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00450-7     Document Type: Article

References (28)

1. 1. a) Tomasz, A. New Eng. J. Med. 1994, 330, 1247.
2. b) Tenover, F.C.; Hughes J. JAMA, 1996, 275, 300.
3. 2. de Lencastre, H.; de Jonge, B.L.M.; Matthews, P.R.; Tomasz, A. J. Antimicrob. Chem. 1994, 33, 7.
4. 3. Tsushima, M.; Tamura, A.; Hara, T.; Iwamatsu, K.; Shibahara, S. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy Abst. 394 1992.
5. 4. Ternansky, R.J.; Draheim, S.E.; Pike, A.J.; Bell, F.W.; West, S.J.; Jordan, C.L.; Wu, C.Y.; Preston, D.A.; Alborn, W. Jr; Kasher, J.S.; Hawkins, B.L. J. Med. Chem. 1993, 36, 1971.
6. 5. Jabès, D.; Rossi, R.; Della Bruna, C.; Perrone, E.; Alpegiani, M.; Andreini, B.P.; Visentin, G.; Zarini, F.; Franceschi, G. Biorg. Med. Chem. Let. 1993, 3, 2165.
7. 6. a) US 5025088, 1991 and US 5240920, 1993, DiNinno, F.P.; Greenlee, M.L.; Salzmann T.N.
8. b) DiNinno, F.; Muthard, D.A.; Salzmann, T.N. Bioorg. Med. Chem. Let. 1993, 3, 2187.
9. c) Meurer, L.C.; Guthikonda, R.N.; Hubert, J.L.; DiNinno, F. Bioorg. Med. Chem. Let. 1995, 5, 767.
10. d) DiNinno, F.; Muthard, D.A.; Salzmann, T.N. Biorg. Med. Chem. Let. 1995, 5, 945.
11. e) Waddell, S.; Ratcliffe, R. Bioorg. Med. Chem. Let. 1995, 5, 1427.
12. f)Sunagawa, M.; Yamaga, H.; Shinagawa, H.; Houchigai, H.; Sumita, Y. Bioorg. Med. Chem. Let. 1994, 4, 2793.
13. 7. a) L695256 was synthesised according to US 5034384, 1991, Greenlee, M.; DiNinno, F.P.; Cama, L.D.; Heck, J.V.
14. b) Imipenem was obtained from commercial sources as Primaxin.
15. 8. All new compounds exhibited spectroscopic properties consistent with the structures given.
16. 9. Shih, D.H.; Baker, F.; Cama, L.; Christensen, B.G. Heterocycles 1984, 21, 29.
17. 10. a) Arnould, J.C.; Landier, F.; Pasquet, M.J. Tetrahedron Lett. 1992, 33, 7133.
18. b) Arnould, J.C.; Landier, F.; Pasquet, M.J. Recent Advances in the chemistry of Anti-Infective Agents, Cambridge, England, July 5-8, 1992.
19. c)Uyeo, S.; Itani, H. Tetrahedron Lett. 1994, 35, 4377.
20. 11. Alpegiani, M.; Bedeschi, A.; Perrone, E.; Zarini, F.; Franceschi, G. Heterocycles 1985, 23, 2255.
21. 12. Jeffrey, P.D.; McCombie, S.W. J. Org. Chem. 1982, 47, 587.
22. 5 cfu/spot. Plates were incubated at 30°C for 48 hours for staphylococci and 37°C + 5% carbon dioxide for S. pneumoniae and enterococci. The MIC was determined as the lowest concentration to inhibit visible growth.
23. 14. Chambers, H.F.; Sachdeva, M.; Kennedy, S. J. Infect. Dis. 1990, 162, 705.
24. 4 cfu. One hour post-infection, the animals were dosed subcutaneously with test compound. Six hours post-infection, thigh tissue was removed and bacteria enumerated.
25. 16. a) Hammond, G. G.; Overbye, K. M.; Silver, L. L. 34th Interscience Conference on Antimicrobial Agents and Chemotherapy Abst. F62 1994.
26. b) Chambers, H. F. Antimicrob. Agents Chemother. 1995, 39, 462.
27. 50 value was defined as the concentration of carbapenem that acylated half of the PBP2′ molecules.
28. 18. Catherall, E. J.; Eaton, N. R.; Hill, G. K.; Merrikin, D. J.; Mizen, L. 29th Interscience Conference on Antimicrobial Agents and Chemotherapy Abst. 90 1989.